After a lengthy and successful career in investment banking, Scott Ryles become chief operating officer at Westlake when the firm launched in 2018, and now acts as a special advisor to the company.

From 2014 to 2018, Ryles was chief operating officer at Kleiner Perkins. In 1999, when Kleiner Perkins asked him to “build a better bank” he realized that driving change excited him…it was contagious. But he wanted to do something more. “Curing cancer, or any other disease, is far more rewarding than any other company or project I have worked on,” he says.

During his career, Ryles has originated and executed more than $100 billion of private placements, IPOs, secondary offerings, convertible securities and mergers and acquisitions for companies in the financial services, utility, natural resources, media and retailing industries, as well as for private and public technology companies in America, Europe and Asia.

At Westlake Village BioPartners, Ryles helped build the foundation of the new firm, led by some of the industry’s most respected scientific talent. Today he plays an active role as an advisor to the firm.

During his 18 years at Merrill Lynch, Ryles held various investment banking positions, including co-head of west coast investment banking, global head of natural resources and global head of technology. Ryles also served as vice chairman of Cowen and Company.

Ryles held numerous senior management and business operations roles throughout his career, including founder and CEO of Epoch Partners, an investment bank acquired by Goldman Sachs in 2001. Ryles served as president and CEO of Home Value Protection and co-founded and served as CEO of Echelon Capital Strategies. He has served on numerous private and public company boards, including KKR Financial and The Gymboree Corporation.

Westlake Village Biopartners - Scott Ryles

Special Advisor